John T. Cole, MD - LSUHSC School of Medicine

Administration	Basic Sciences	Clinical Sciences	Centers of Excellence
Admissions Alumni Affairs Community and Minority Health Education Computer Support Continuing Education Dean's Office Faculty & Institutional Affairs Fiscal Affairs Libraries Medical Education Research Student Affairs	Biochemistry & Molecular Biology Cell Biology & Anatomy Genetics Microbiology, Immunology & Parasitology Pharmacology Physiology	Anesthesiology Dermatology Family Medicine Internal Medicine Emergency Medicine Gastroenterology Physical Medicine & Rehabilitation Neurology Neurosurgery OB/GYN Ophthalmology Orthopaedics Otorhinolaryngology Pathology Pediatrics Psychiatry Radiology Surgery Urology	Alcohol and Drug Abuse Center Cardiovascular Center Center on Healthy Aging Center for Molecular and Human Genetics Epilepsy Center Eye Center Ernest N. Morial Asthma, Allergy, and Respiratory Disease Center Gene Therapy Program Low Vision Center Neurosciences Center The Research Institute For Children Stanley S. Scott Cancer Center

Faculty

Residency

Fellowship

Research

Links

Sections

Curriculum

New Orleans

Department Title

	John T. Cole, MD Acting Chief, Hematology/Oncology Clinical Professor of Medicine 2020 Gravier Street 7th Floor, Suite D New Orleans, LA 70112 Ph. (504) 568-2370 Fax (504) 568-2127
Degrees	MD - 1981 LSU School of Medicine
Bio	Assistant Professor of Clinical Medicine Columbia University College of Physicians and Surgeons 7/87 – 6/89 Staff Member, Section of Hematology/Oncology Ochsner Clinic 7/89 - present Section Head Department of Hematology and Medical Oncology Ochsner Clinic 10/89 - present BOARD CERTIFICATIONS: Diplomate, American Board of Internal Medicine, 1984 Hematology, 1986 Oncology, 1987
Selected Publications	Kardinal CG, Cole JT; Breast Cancer (in) The Chemotherapy Source Book. 4th edition. MC Perry, Editor, Chapter 34, 363-407. Lippincott, Williams, Wilkins. 2008 Perez EA, Suman VJ, Fitch TR, Mailliard JA, Ingle JN, Cole JT, Veeder MH, Flynn PJ, Walsh DJ, Addo FK: A Phase II Trial of Docetaxel and Carboplatin as First-Line Chemotherapy for Metastatic Breast Cancer: NCCTG Study N9932. Oncology 2005; 69:117-121. Cole JT, McElroy EA, Marques CB, Castillo RA, Gralla RJ: Phase I study of weekly paclitaxel and vinorelbine in patients with advanced solid tumors. Proceedings of American Society of Clinical Oncology 22:606-150, 2003. Gonzales-Angulo AM, Suarez J, Fuloria J, Cole JT, Kardinal CG: Prognostic implications of immunohistochemical detection in sentinel lymph nodes of breast cancer patients. Proceedings of American Society of Clinical Oncology 21:3568-887, 2003. “Locally Advanced Breast Cancer” John T. Cole in Cancer of the Breast, 5th Edition, Donegan WL and Spratt JS, Ed. W.B. Sanders. pg 579 – 595, 2002. Natale RB, Skarin A, Maddox AM, Hammond LA, Thomas R, Gandara DR, Gerstein H, Panella T, Cole J, Jahanzeb M, Kash J, Hamm J, Langer C, Saleh M, Stella P, Heyes A, Helms L, Ochs J, Averbuch S, Wolf M, Kay A: Improvement in symptoms and quality of life for advanced non-small cell lung cancer patients receiving ZD1839 (“Iressa”) in IDEAL 2. Proceeding of American Society of Clincal Oncology 21:1167-292A, 2002. “Chemotherapy of Breast Cancer” Carl G. Kardinal and John T. Cole in Chemotherapy Source Book, 3rd Edition, Michael C. Perry, M.D. Editor; pg 647-689, 2001. Buckner JC, Schomberg PJ, McGinnis WL, Cascino TL, Scheithauer BW, O’Fallon J, Morton RF, Kuross SA, Mailliard JA, Hatfield AK, Cole JT, Steen PD, Bernath AM: A Phase III Study of Radiation Therapy plus Carmustine with or without Recombinant Interferon-α in the Treatment of Patients with Newly Diagnosed High-Grade Glioma. Cancer 92:420-33, 2001.